The Non-Communicable Disease (NCD) Consortium Recognized as a Center of Excellence Institution for Tobacco Control Efforts

For Immediate Release

August 11, 2017;8:45am

DPHSS Release No. 2017-063

THE NON-COMMUNICABLE DISEASE (NCD) CONSORTIUM RECOGNIZED AS A CENTER OF EXCELLENCE INSTITUTION FOR TOBACCO CONTROL EFFORTS

The Department of Public Health and Social Services in partnership with the Non-Communicable Disease (NCD) Consortium, will host several batches of Philippines-based medical doctors as part of the Center of Excellence (CENTREX) study tour program from August 16, 2017 to October 19, 2017. The CENTREX study tour is one of the flagship Continuing Medical Education (CME) projects of LRI-Therapharma. LRI-Therapharma is a division of Unilab Inc., the largest Filipino pharmaceutical company.

The CENTREX-Guam study tour will include lectures and a panel discussion comprised of local physicians and designated key stakeholders / community advocates, to showcase activities and/or research related to tobacco control policies and the prevention of non-communicable diseases, such as cardiovascular disease. Activities are balanced and unbiased, with presentations that reflect the expertise and opinions of the speakers, with no product endorsement involved. The visiting doctors also plan on touring the Guam Congress Building in Hagåtña and the Amot Tao’tao Tano Farm in Dededo.

As a cardiometabolic company, LRI-Therapharma supports the promotion of healthy lifestyle interventions as a fundamental factor in curbing the rise of cardiovascular disease in the Philippines. One of the most important of these is the need to curb tobacco use. In support of government initiatives, the company is keenly interested in partnering with the Guam NCD Consortium to help raise awareness of its tobacco control and NCD prevention advocacy.

The objectives of the CENTREX-Guam study tour are to (1) promote anti-smoking advocacy as an integral aspect in cardiovascular disease management, and (2) to share and increase awareness of the Guam advocacy methodology and experience among Filipino physicians. 

For more information please contact Ms. Liz Guerrero or Mr. Christopher Surla from the DPHSS Tobacco Prevention and Control Program, at 735-7303 or 735-7334.